These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2461790)

  • 1. [Genetic engineering and trends in the research on new vaccines].
    Hofnung M
    C R Seances Soc Biol Fil; 1988; 182(2):141-57. PubMed ID: 2461790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
    Gałazka A
    Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
    [No Abstract]   [Full Text] [Related]  

  • 3. Salmonella-based vaccines for infectious diseases.
    Kwon YM; Cox MM; Calhoun LN
    Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular basis for constructing artificial immunogens].
    Khaitov RM
    Mol Gen Mikrobiol Virusol; 1987 Nov; (11):3-8. PubMed ID: 3328044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies against an old plague: genetically engineered tuberculosis vaccines.
    Dreher D; Kok M; Pechère JC; Nicod LP
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1925-9. PubMed ID: 11189437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New vaccination strategies].
    Plotkin SA
    Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral vaccines].
    Girard M
    Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of vaccine stability.
    Volkin DB; Burke CJ; Sanyal G; Middaugh CR
    Dev Biol Stand; 1996; 87():135-42. PubMed ID: 8854010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HBV-related antigens and genetic engineering].
    Hamada F; Mizuno K
    Rinsho Byori; 1984 Nov; 32(11):1177-83. PubMed ID: 6240548
    [No Abstract]   [Full Text] [Related]  

  • 18. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB; Ilyichev AA; Eroshkin AM; Karpenko LI; Pokrovsky AG; Pereboev AV; Svyatchenko VA; Ignat'ev GM; Smolina MI; Melamed NV; Lebedeva CD; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):129-37. PubMed ID: 8717396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.